Literature DB >> 25970431

Immunocytochemical Diagnosis of Limbal Stem Cell Deficiency: Comparative Analysis of Current Corneal and Conjunctival Biomarkers.

Muriel Poli1, Carole Burillon, Celine Auxenfans, Marie-Rose Rovere, Odile Damour.   

Abstract

PURPOSE: To evaluate and compare corneal and conjunctival biomarkers for immunocytochemical diagnosis of limbal stem cell deficiency (LSCD).
METHODS: In accordance with the current literature, we selected K12 as the corneal biomarker and K7/K13/K19/MUC5AC as the conjunctival ones. The specificity and accuracy for each biomarker were assessed and compared on 10 healthy subjects and tissues of deceased donors. Twelve eyes of 9 patients clinically suspected of LSCD were enrolled. Epithelial cells (ECs) from the central cornea were collected using impression cytology (IC) and assessed for each biomarker. The presence of conjunctival cells in the central cornea was diagnostic proof of LSCD, whereas the detection of corneal residual cells would quantify the degree of LSCD.
RESULTS: K12 and K7/K13/MUC5AC are, respectively, highly specific of corneal and conjunctival differentiation, whereas K19 is not. Normal corneal ECs are not desquamative enough to be suitable for IC. Among 12 eyes with suspected LSCD, 84% (10 of 12) of IC samples were suitable for analysis. K3/K7/K19 immunostaining was positive in 100%, MUC5AC in 40%, and K12 was never observed.
CONCLUSIONS: Clinical examination can lead to misdiagnosis of LSCD. Immunocytochemical detection of K7/K13 on corneal ECs collected by IC is reproducible, noninvasive, and highly effective in this indication, but without any quantification of the degree of the disease. This time-consuming technique requires skilled technicians and laboratory facilities, reserving it for planned limbal reconstruction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25970431     DOI: 10.1097/ICO.0000000000000457

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  15 in total

1.  A Case of Corneal Neovascularization Misdiagnosed as Total Limbal Stem Cell Deficiency.

Authors:  Qihua Le; C Michael Samson; Sophie X Deng
Journal:  Cornea       Date:  2018-08       Impact factor: 2.651

2.  Diagnostic criteria for limbal stem cell deficiency before surgical intervention-A systematic literature review and analysis.

Authors:  Qihua Le; Tulika Chauhan; Sophie X Deng
Journal:  Surv Ophthalmol       Date:  2019-07-02       Impact factor: 6.048

3.  Cytokeratin 13 Is a New Biomarker for the Diagnosis of Limbal Stem Cell Deficiency.

Authors:  Qingfeng Liang; Qihua Le; Leying Wang; Daniel Cordova; Elfren Baclagon; Sheyla González Garrido; Mary Levin; Yusheng Jin; Chi-Hong Tseng; Jianyu Rao; Sophie X Deng
Journal:  Cornea       Date:  2021-11-03       Impact factor: 3.152

Review 4.  The diagnosis of limbal stem cell deficiency.

Authors:  Qihua Le; Jianjiang Xu; Sophie X Deng
Journal:  Ocul Surf       Date:  2017-11-04       Impact factor: 5.033

5.  Existence of Normal Limbal Epithelium in Eyes With Clinical Signs of Total Limbal Stem Cell Deficiency.

Authors:  Eric Chan; Qihua Le; Andres Codriansky; Jiaxu Hong; Jianjian Xu; Sophie X Deng
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

6.  Classification of Limbal Stem Cell Deficiency Using Clinical and Confocal Grading.

Authors:  Carolina Aravena; Kansu Bozkurt; Pichaya Chuephanich; Chantaka Supiyaphun; Fei Yu; Sophie X Deng
Journal:  Cornea       Date:  2019-01       Impact factor: 2.651

Review 7.  Limbal stem cell diseases.

Authors:  Clémence Bonnet; JoAnn S Roberts; Sophie X Deng
Journal:  Exp Eye Res       Date:  2021-02-08       Impact factor: 3.467

Review 8.  An Insight into the Difficulties in the Discovery of Specific Biomarkers of Limbal Stem Cells.

Authors:  Zhi Hou Guo; Wei Zhang; Yang Yan Sheng Jia; Qing Xiu Liu; Zhao Fa Li; Jun Sheng Lin
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

9.  Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing.

Authors:  Chi-Chin Sun; Hsiao-Ting Chiu; Yi-Fang Lin; Kuo-Ying Lee; Jong-Hwei Su Pang
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

Review 10.  From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU.

Authors:  Graziella Pellegrini; Alessandro Lambiase; Claudio Macaluso; Augusto Pocobelli; Sophie Deng; Gian Maria Cavallini; Roza Esteki; Paolo Rama
Journal:  Regen Med       Date:  2016-04-19       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.